Researchers reported the generation of a mouse model based on the neuromedin U receptor 1 promoter as a driver for simultaneous expression of Cre recombinase and green fluorescent protein, which enabled gene targeting in group 2 ILCs without affecting other innate and adaptive immune cells.
[Nature]